A corporate-backed genomics accelerator providing lab space, sequencing access, and capital.
The Illumina Accelerator supports genomics startups with something few investors can offer: sequencing capacity, laboratory space, and technical support from the company that makes much of the underlying instrumentation.
For a genomics company, that access materially changes early burn — sequencing costs and lab infrastructure are often the largest line items before any revenue exists.
Alumni work across clinical diagnostics, single-cell analysis, agricultural genomics, and synthetic biology tooling.
The programme is a clear example of corporate-strategic accelerating: the sponsor benefits from an expanded sequencing ecosystem, and founders benefit from infrastructure they could not otherwise afford.
Global Capital Network connects accelerator graduates with investors ready for the next round.
Explore OpportunitiesAll Accelerators.png)




